Palvella Therapeutics Announces Three Poster Presentations Highlighting New Data in Microcystic Lymphatic Malformations and DSAP at Fall Clinical Dermatology 2026
Comprehensive Real-World Claims Analysis Identifies an Estimated 154,986 Patients Diagnosed With DSAP in the U.S. WAYNE, Pa., Oct. 12, 2026 (GLOBE NEWSWIRE)– Palvella Therapeutics, Inc. (Palvella or …